Tag Archives: NHS

Invacare adds a range of specialist controls to its LiNX powerchair range

CARDIFF, United Kingdom, Aug-24-Aug-2017 — /EuropaWire/ — Global brand leader Invacare is once again raising the bar in the powerchair market, following on from the successful launch of the LiNX control system last year. Invacare has taken the smart technology a step further with a new touch screen remote, in-built Bluetooth technology, enhanced programming features and a range of specialist controls, all available on the remarkable Invacare LiNX powerchair range.

Touch screen remote
Introducing next generation technology to powerchairs, Invacare is pleased to present the REM400 remote with its 3.5” interactive screen that requires minimal force to operate. Following extensive customer-insight research, this innovative remote can be configured to a users’ physical and cognitive ability, thanks to its extensive functional capabilities. Also available is a REM500, a display only version of the REM400. Both remotes can be used with a wide range of specialist controls.

Bluetooth technology
The REM400 and REM500 controls have built-in Bluetooth technology to allow users to connect to their PC, Mac and compatible Android devices that have built-in HID functionality.

Enhanced programming features
The LiNX system now allows professionals to mix and match the drive, seating and environmental controls in order to customise the display to suit the user’s lifestyle. E.g. The profiles can be customised by names such as Home, Outdoor and Work, with functions specific to each one. Profiles can also be set by user input options i.e. head control.

Another new feature is the ability to adjust the joystick commands. The basic commands on a powerchair are forward, reverse, left and right but there are also other commands such as tilt, recline, lights, horns etc. to consider. The REM400 and REM500 allow these commands to be changed to suit the user, based on frequency or even by accessibility.

Specialist controls
To maximise a user’s control and independence, the REM400 and REM500 allow a selection of specialist user inputs to be used on Invacare’s remarkable powerchairs. They range from head controls, chin controls, Sip ‘n’ puff systems, joystick options, proximity switches and dual controls, allowing Invacare to provide a control solution for many powerchair users. To help professionals select the best control for a powerchair user, Invacare has put together a useful app with five simple steps to assist with the process. Take a look at the app by visiting www.linx4you.com plus it can downloaded from the Google Play Store and Apple App Store.

TDX SP2 base updates
The above offering is available on all Invacare LiNX powerchairs, with a selection of the specialist controls only compatible with the TDX SP2 Ultra Low Maxx – and it is with this chair that Invacare is now able to fully enter the complex rehab market. For more information on the TDX SP2 Ultra Low Maxx, visit www.invacareULM.com. As well as feature heavy, the TDX SP2 base itself can be customised thanks to the 10 contemporary shroud and rim insert options available which sit nicely on its new black tyres and castors. There is a new single sided fork option on the front and rear castors.

SOURCE: EuropaWire

VNUS Closure Procedure to save NHS ‘millions’

As the NHS faces budget restrictions, a non-surgical treatment for varicose veins (http://www.vnus.co.uk) has the potential to save the NHS millions of pounds.

Government ministers have promised that frontline services will be protected from cuts, but the NHS Confederation believes that this is unlikely to be achieved given the scale of the savings needed.

It estimates that the health service will have to make savings of £20bn over the next four years, as demand for healthcare continues to grow but increases in funding come to an end.

It is estimated that the VNUS Closure Procedure could potentially save the NHS £17 million, while helping 7,000 patients avoid further treatment due to failed alternative methods.

“This procedure has enabled many NHS Trusts throughout the country to take a very common operation out of the operating theatre and into treatment rooms, helping to free-up theatres for other cases,” said, Michael Branagan-Harris, Group Manager for NHS Medical Device Market Access For Innovative Medical Devices.

The VNUS Closure Procedure involves a hospital stay of just a couple of hours, treatment under local, rather than general anaesthetic, and a much faster recovery time.

Most patients undergoing a VNUS procedure walk out of the treatment room unaided and are usually able to return home and resume work within a day, with little or no pain.

For the NHS, the procedure is also much less resource-intensive than surgery. Conventional varicose vein stripping is a common operation, taking-up a great deal of operating theatre time.

For same costs, a further 25,000 patients could be treated earlier and avoid pain, or discomfort.

As the VNUS Closure procedure can be carried-out in a treatment room, it has the potential to free-up theatre-time, enabling the NHS to treat other serious conditions more quickly and so reduce waiting-times.

Via EPR Network
More Healthcare press releases

Quoteboffin.co.uk Urges Health Providers To Maintain Momentum In Light Of Improving Cancer Survival Rates

Survival rates for some cancers has doubled since the 1970s. Now health and life insurance comparison site, QuoteBoffin.co.uk, is calling on health organisations to continue their good work.

Following research by leading organisation Cancer Research UK, it has emerged that survival rates for some cancers including bowel, breast and ovarian have doubled over the past four decades.

Comparisons between survival rates for those with cancer in the 1970s and people with the disease in the late noughties show vast improvements in the number of patients expected live more than ten years with the disease.

Breast and bowel cancer have seen remarkable improvements in survival rates with the number of people living at least ten after diagnosis years jumping from 40% to 77% and 23% to over 50% respectively.

Despite the improvements, health organisations and cancer charities are still calling for more work to be done to improve cancer patients chances of survival.

A spokesperson from QuoteBoffin.co.uk joined the calls for further research, with cancer treating drugs high on the agenda:

“It’s encouraging to see such a stark improvement in cancer survival rates in such a short space of time.

“As technology improves so does our ability to detect and treat cancer earlier and earlier and this brings with it its own set of problems.

“No longer is cancer treatment about prolonging a patient’s life, it’s about completely curing the disease altogether so now we must put more and more money and time into crafting and fine tuning a range of drugs and treatments that can be applied to the disease at any stage.”

Via EPR Network
More Healthcare press releases

End Of NHS Funded Homeopathy Could Leave Some UK Residents With No Other Choice But To Seek Private Medical Insurance

After examining the claims of homeopathy, the House of Commons select committee on science and technology has concluded that the NHS should no longer provide funding for the treatment.

End Of NHS Funded Homeopathy Could Leave Some UK Residents With No Other Choice But To Seek Private Medical Insurance

Homeopathy – a 200-year-old complementary medical practice – uses heavily diluted substances which are thought to cause similar symptoms to the illnesses they are being used to treat; thus triggering the body’s natural healing process.

Millions of patients across the globe swear by homeopathic treatments while others dismiss it as nothing more than a ‘placebo’.

Whichever side of the debate you’re on, life insurance comparison website – QuoteBoffin.co.uk – believes that every patient should have the right to seek medical care they feel is appropriate for them.

A spokesperson for QuoteBoffin.co.uk said: “Freedom of choice is something that Britain prides itself on. Removing homeopathy f r o m the NHS medical roster means a percentage of patients are being denied the right to choose a method of treatment they believe is most appropriate or may work better for them than other forms of medicine.

With health insurance providers still offering homoeopathy treatments via carefully selected homeopathic specialists, patients wishing to pursue this line of treatment may have no other option but to seek private health cover.”

Complimentary therapies and medicines are available via some of the UK’s biggest health insurance providers such as AXA PPP and BUPA.

Patients needn’t worry about paying through the nose for homeopathic treatment out with the NHS claims QuoteBoffin.co.uk: “The end of homoeopathy on the NHS doesn’t mean the end of homoeopathy full stop. Health insurance premiums start f r o m as little as £5 per month which is a small price to pay for peace of mind and first class healthcare which covers homeopathy and beyond.

With the rise and rise of price comparison websites that allow consumers to check insurance prices, there’s no reason why you can’t get a good deal on an insurance package that allows you to retain freedom of choice with regard to medical care.”

Via EPR Network
More Healthcare press releases